Blood test for donor DNA in kidney transplant care
Part of Kidney & urinary clinical trials.
This trial is testing whether a simple blood test that looks for donor DNA can help doctors take better care of kidney transplant patients. It may help detect early signs of rejection and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have received a kidney transplant from a living or deceased donor (this could be a repeat transplant if your first one failed)
- You are willing to sign a consent form and follow the study procedures
- If you are a woman who could become pregnant, you are willing to use effective birth control during the study
- You are not currently in prison or under legal guardianship
- You have not received a transplant of more than one organ (like a kidney and pancreas together)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
This trial tests a new way to monitor children and young adults who have received a kidney transplant. It aims to personalize their anti-rejection medications using less-invasive checks, instead of relying on frequent biopsies. It could reduce discomfort and improve long-term kidney health.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study tests a new blood test (called cfDNA) that may help doctors detect early signs of kidney transplant rejection before problems develop. The goal is to help keep your transplanted kidney healthy longer by catching issues early.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
This study looks at special blood tests to help predict when kidney transplant rejection might happen. If the markers work, they could help doctors catch rejection earlier and adjust treatment sooner.
Hear when a new Renal Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.